Varin-Blank N - Search Results

1

hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.

Germani A, Romero F, Houlard M, Camonis J, Gisselbrecht S, Fischer S, Varin-Blank N. Germani A, et al. Mol Cell Biol. 1999 May;19(5):3798-807. doi: 10.1128/MCB.19.5.3798. Mol Cell Biol. 1999. PMID: 10207103 Free PMC article.

2

Vav binding to heterogeneous nuclear ribonucleoprotein (hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner.

Romero F, Germani A, Puvion E, Camonis J, Varin-Blank N, Gisselbrecht S, Fischer S. Romero F, et al. J Biol Chem. 1998 Mar 6;273(10):5923-31. doi: 10.1074/jbc.273.10.5923. J Biol Chem. 1998. PMID: 9488731 Free article.

3

SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis.

Germani A, Bruzzoni-Giovanelli H, Fellous A, Gisselbrecht S, Varin-Blank N, Calvo F. Germani A, et al. Oncogene. 2000 Dec 7;19(52):5997-6006. doi: 10.1038/sj.onc.1204002. Oncogene. 2000. PMID: 11146551

4

Vav1 is a component of transcriptionally active complexes.

Houlard M, Arudchandran R, Regnier-Ricard F, Germani A, Gisselbrecht S, Blank U, Rivera J, Varin-Blank N. Houlard M, et al. J Exp Med. 2002 May 6;195(9):1115-27. doi: 10.1084/jem.20011701. J Exp Med. 2002. PMID: 11994417 Free PMC article.

5

SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway.

Germani A, Prabel A, Mourah S, Podgorniak MP, Di Carlo A, Ehrlich R, Gisselbrecht S, Varin-Blank N, Calvo F, Bruzzoni-Giovanelli H. Germani A, et al. Oncogene. 2003 Dec 4;22(55):8845-51. doi: 10.1038/sj.onc.1206994. Oncogene. 2003. PMID: 14654780

6

Characterization of VIK-1: a new Vav-interacting Kruppel-like protein.

Houlard M, Romero-Portillo F, Germani A, Depaux A, Regnier-Ricard F, Gisselbrecht S, Varin-Blank N. Houlard M, et al. Oncogene. 2005 Jan 6;24(1):28-38. doi: 10.1038/sj.onc.1208043. Oncogene. 2005. PMID: 15558030

7

Dimerization of hSiah proteins regulates their stability.

Depaux A, Regnier-Ricard F, Germani A, Varin-Blank N. Depaux A, et al. Biochem Biophys Res Commun. 2006 Sep 29;348(3):857-63. doi: 10.1016/j.bbrc.2006.07.092. Epub 2006 Jul 28. Biochem Biophys Res Commun. 2006. PMID: 16899216

8

A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.

Depaux A, Regnier-Ricard F, Germani A, Varin-Blank N. Depaux A, et al. Oncogene. 2007 Oct 11;26(46):6665-76. doi: 10.1038/sj.onc.1210486. Epub 2007 May 28. Oncogene. 2007. PMID: 17533377

9

Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.

Simon C, Dondi E, Chaix A, de Sepulveda P, Kubiseski TJ, Varin-Blank N, Velazquez L. Simon C, et al. Blood. 2008 Nov 15;112(10):4039-47. doi: 10.1182/blood-2008-05-154849. Epub 2008 Aug 27. Blood. 2008. PMID: 18753636 Free article.

10

Mutation of Vav1 adaptor region reveals a new oncogenic activation.

Razanadrakoto L, Cormier F, Laurienté V, Dondi E, Gardano L, Katzav S, Guittat L, Varin-Blank N. Razanadrakoto L, et al. Oncotarget. 2015 Feb 10;6(4):2524-37. doi: 10.18632/oncotarget.2629. Oncotarget. 2015. PMID: 25426554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters